Your browser doesn't support javascript.
loading
Plasma from patients with vaccine-induced immune thrombotic thrombocytopenia displays increased fibrinolytic potential and enhances tissue-type plasminogen activator but not urokinase-mediated plasminogen activation.
Keragala, Charithani B; McFadyen, James D; Ho, Heidi; McCutcheon, Fiona M; Liu, Zikou; Stevens, Hannah; Monagle, Paul; Chunilal, Sanjeev; Medcalf, Robert L; Tran, Huyen.
Affiliation
  • Keragala CB; Australian Centre for Blood Diseases, the Central Clinical School, Monash University, Melbourne, Victoria, Australia; Department of Hematology, Monash Health, Clayton, Victoria, Australia; School of Clinical Sciences, Monash Health, Monash University, Clayton, Victoria, Australia.
  • McFadyen JD; Australian Centre for Blood Diseases, the Central Clinical School, Monash University, Melbourne, Victoria, Australia; Atherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia; Department of Hematology, Alfred Hospital, Melbourne, Victoria, Aus
  • Ho H; Australian Centre for Blood Diseases, the Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • McCutcheon FM; Australian Centre for Blood Diseases, the Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Liu Z; Australian Centre for Blood Diseases, the Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Stevens H; Australian Centre for Blood Diseases, the Central Clinical School, Monash University, Melbourne, Victoria, Australia; Atherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia; Department of Hematology, Alfred Hospital, Melbourne, Victoria, Aus
  • Monagle P; Department of Pediatrics, University of Melbourne, Melbourne, Victoria, Australia; Hematology Research, Murdoch Children's Research Institute, Melbourne, Victoria, Australia; Clinical Hematology, Royal Children's Hospital, Parkville, Victoria, Australia; Kids Cancer Centre, Sydney Children's Hospita
  • Chunilal S; Department of Hematology, Monash Health, Clayton, Victoria, Australia; School of Clinical Sciences, Monash Health, Monash University, Clayton, Victoria, Australia.
  • Medcalf RL; Australian Centre for Blood Diseases, the Central Clinical School, Monash University, Melbourne, Victoria, Australia. Electronic address: huyen.tran@monash.edu.
  • Tran H; Australian Centre for Blood Diseases, the Central Clinical School, Monash University, Melbourne, Victoria, Australia; Department of Hematology, Alfred Hospital, Melbourne, Victoria, Australia. Electronic address: huyen.tran@monash.edu.
J Thromb Haemost ; 22(3): 785-793, 2024 Mar.
Article in En | MEDLINE | ID: mdl-37944898
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytopenia / Thrombosis / Blood Coagulation Disorders / Venous Thromboembolism / Antifibrinolytic Agents Limits: Humans Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2024 Document type: Article Affiliation country: Australia Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytopenia / Thrombosis / Blood Coagulation Disorders / Venous Thromboembolism / Antifibrinolytic Agents Limits: Humans Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2024 Document type: Article Affiliation country: Australia Country of publication: United kingdom